Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
10/16/2003 | WO2003037159A3 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
10/16/2003 | WO2003035835A3 Glycoprotein compositions |
10/16/2003 | WO2003035790A3 Improved method for generating an aerosol |
10/16/2003 | WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents |
10/16/2003 | WO2003029413A3 A novel g protein-coupled receptor, gave 10 |
10/16/2003 | WO2003026626A3 Modified release dosage forms |
10/16/2003 | WO2003015707A3 Method for treating lung cancers |
10/16/2003 | WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
10/16/2003 | WO2003013427A3 A method for preparing fluticasone derivatives |
10/16/2003 | WO2003011314A3 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
10/16/2003 | WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
10/16/2003 | WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases |
10/16/2003 | WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions |
10/16/2003 | WO2002080884A3 Powder inhaler formulations |
10/16/2003 | WO2002064134A3 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies |
10/16/2003 | WO2002055101A9 Storage stable powder compositions of interleukin-4 receptor |
10/16/2003 | WO2001089527A3 Pharmaceutical composition comprising loratadine and a nasal decongestant |
10/16/2003 | US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof |
10/16/2003 | US20030195257 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity |
10/16/2003 | US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents |
10/16/2003 | US20030195232 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
10/16/2003 | US20030195230 Substituted amine derivatives and methods of use |
10/16/2003 | US20030195222 Substituted pyrimidinones and pyrimidinthiones |
10/16/2003 | US20030195221 Substituted indolizine-like compounds and methods of use |
10/16/2003 | US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors |
10/16/2003 | US20030195214 Cancer treatment |
10/16/2003 | US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta |
10/16/2003 | US20030195201 Vanilloid receptor ligands and their use in treatments |
10/16/2003 | US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
10/16/2003 | US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse |
10/16/2003 | US20030195181 Laulimalide derivatives |
10/16/2003 | US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates |
10/16/2003 | US20030195172 Novel phosphonic acid compounds as inhibitors of serine proteases |
10/16/2003 | US20030195169 Such as (S)-phosphoric acid mono-(3-(5-chloro-2-methoxy-phenyl)-3-fluoro-2-oxso-6-trifluoromethyl-2,3 -dihydro-indol-1-ylmethyl)ester; for modulation of large-conductance calcium-activated potassium (BK) channels |
10/16/2003 | US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs |
10/16/2003 | US20030195160 Sodium channel blockers |
10/16/2003 | US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides |
10/16/2003 | US20030194456 Extract of the leaves and/or stem of Argemone mexicana plant for treatment of psoriasis and related biochemical and immunological disorders |
10/16/2003 | US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof |
10/16/2003 | US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders |
10/16/2003 | US20030194391 Vaccine |
10/16/2003 | US20030194378 Novel aerosol formulation containing a polar fluorinated molecule |
10/16/2003 | US20030192551 Methods and devices for use in performing pulmonary procedures |
10/16/2003 | US20030192550 Methods and devices for use in performing pulmonary procedures |
10/16/2003 | CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
10/16/2003 | CA2481879A1 Hydroxamic acid derivatives |
10/16/2003 | CA2481850A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
10/16/2003 | CA2481463A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
10/16/2003 | CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same |
10/16/2003 | CA2481028A1 Hormone replacement therapy |
10/16/2003 | CA2480818A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
10/16/2003 | CA2480790A1 Use of antithrombin iii in treating acute lung injury |
10/16/2003 | CA2480482A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
10/16/2003 | CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
10/16/2003 | CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components |
10/16/2003 | CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
10/16/2003 | CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
10/16/2003 | CA2479520A1 P38 kinase inhibitors for treating mucus hypersecretion_ |
10/16/2003 | CA2478934A1 Process for producing oil and fat composition containing hydrophobic components of glycyrrhiza |
10/16/2003 | CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
10/15/2003 | EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases |
10/15/2003 | EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases |
10/15/2003 | EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases |
10/15/2003 | EP1352659A1 Combination drugs |
10/15/2003 | EP1352646A2 Lozenge containing ambroxol |
10/15/2003 | EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
10/15/2003 | EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
10/15/2003 | EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
10/15/2003 | EP1351962A2 Thienopyrimidine |
10/15/2003 | EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
10/15/2003 | EP1351953A1 Quinoline derivatives as nk-3 antagonists |
10/15/2003 | EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor |
10/15/2003 | EP1351933A1 Il-8 receptor antagonists |
10/15/2003 | EP1351929A1 Nitric oxide synthase inhibitor phosphate salt |
10/15/2003 | EP1351924A2 Diamines as modulators of chemokine receptor activity |
10/15/2003 | EP1351704A2 Storage stable powder compositions of interleukin-4 receptor |
10/15/2003 | EP1351688A1 Urotensin-ii receptor antagonists |
10/15/2003 | EP1351687A2 Urotensin-ii receptor antagonists |
10/15/2003 | EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
10/15/2003 | EP1268471B1 N-heterocyclic derivatives as nos inhibitors |
10/15/2003 | EP1259508B1 Novel biarylcarboxamides |
10/15/2003 | EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
10/15/2003 | EP1212316B1 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
10/15/2003 | EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease |
10/15/2003 | EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein |
10/15/2003 | EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
10/15/2003 | CN1449446A Streptococcus antigens |
10/15/2003 | CN1449396A Carbamates derived from arylalkylamines |
10/15/2003 | CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
10/15/2003 | CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
10/15/2003 | CN1449377A Inhibitors of alpha4 mediated cell adhesion |
10/15/2003 | CN1449288A Pharmaceutical formulation of salmeterol and fluticasone propionate |
10/15/2003 | CN1449287A Fused pyrrolocarbazoles against inflammation |
10/15/2003 | CN1449285A Use of il-8 receptor antagonists in the treatment of virus infections |
10/15/2003 | CN1449278A Lung surfactant compositions with dynamic swelling behaviour |
10/15/2003 | CN1448179A Application of bicoptis for injection in preparation of medicine for curing serious acute respiratory tract syndrome |
10/15/2003 | CN1448173A Cymose buckwheat rhizome preparation,production method and use thereof |
10/15/2003 | CN1448169A Traditional Chinese medicine for treating chronic trachitis, and method for preparing same |
10/15/2003 | CN1448131A Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof |
10/15/2003 | CN1448081A Pear, peach and apricot honey sugar slab for prevention and cure of cough and asthma |